Skip to main content

artificial intelligence

By Anthony Vecchione | 02:12 pm | October 15, 2024
The algorithms are used to detect valvular heart disease.
By HIMSS TV | 11:36 pm | October 11, 2024
Troy Foster, Stanford Health Care's director of digital health, discusses expanding use cases for AI among the health system's clinicians and nurses to reduce workload - and how vendors can help lower patient risk.
By Anthony Vecchione | 11:21 pm | October 11, 2024
The aim is to streamline workflows, improve data integration and make better use of AI to deliver positive outcomes.
By Jessica Hagen | 02:44 pm | October 10, 2024
The company will use the funds to expand its partnerships with Athena, Oracle Cerner, Epic and MEDITECH, and to enhance its offerings, Suki Assistant and Suki Platform.
By Anthony Vecchione | 02:21 pm | October 08, 2024
The alliance aims to streamline clinical workflows for providers by creating a suite of AI-enabled tools.
By Jessica Hagen | 07:05 pm | September 30, 2024
OpenAI has launched the OpenAI Academy to support developers and companies in low- and middle-income countries who are leveraging AI to solve problems in their communities.
By HIMSS TV | 07:00 am | September 24, 2024
Peter Bonis, chief medical officer of Wolters Kluwer Health, discusses health provider and consumer skepticism around AI, supporting trust in AI, the adoption cycle of the technology, and the importance of understanding its limitations.
By Jessica Hagen | 09:00 am | September 10, 2024
Hippocratic AI and Adtalem’s Chamberlain University and Walden University will develop a certification program for nurses to evaluate and assess AI use in healthcare.
By HIMSS TV | 07:00 am | September 09, 2024
Dr. Traci Granston, VP of clinical strategy at Cohere Health, discusses intelligent prior authorization using AI to speed up the approval process and how it helps providers receive payment more quickly.
By Anthony Vecchione | 02:43 pm | September 06, 2024
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.